Iodinated NanoClusters as an inhaled computed tomography contrast agent for lung visualization

Molecular Pharmaceutics

Volumn 7, Issue 4, 2010, Pages 1274-1282

  Aillon, Kristin L ^a   El Gendy, Nashwa ^a,b   Dennis, Connor ^d   Norenberg, Jeffrey P ^a,b   McDonald, Jacob ^c   Berkland, Cory ^a,d  

^a UNIVERSITY OF KANSAS   (United States)

^b Beni Suef University   (Egypt)

^c LOVELACE RESPIRATORY RESEARCH INSTITUTE   (United States)

^d University of Kansas   (United States)

Author keywords

aerosol; contrast agent; CT imaging; N1177; NanoCluster; particle engineering

Indexed keywords

DIATRIZOATE; N 1177; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; CONTRAST ENHANCEMENT; DRUG DELIVERY SYSTEM; IMAGE RECONSTRUCTION; LUNG PARENCHYMA; NONHUMAN; PRIORITY JOURNAL; RAT; SCANNING ELECTRON MICROSCOPY;

ADMINISTRATION, INHALATION; ANIMALS; CONTRAST MEDIA; IODINE; LUNG; MALE; NANOSTRUCTURES; NANOTECHNOLOGY; RATS; RATS, INBRED F344; RATS, SPRAGUE-DAWLEY; TOMOGRAPHY, X-RAY COMPUTED;

EID: 77955250536     PISSN: 15438384     EISSN: 15438392     Source Type: Journal    
DOI: 10.1021/mp1000718     Document Type: Article

References (34)

1. Brown, L. R.; Muhm, J. R. Computed tomography of the thorax. Current perspectives Chest 1983, 83, 806-813
2. Islam, T.; Harisinghani, M. G. Overview of nanoparticle use in cancer imaging Cancer Biomarkers 2009, 5, 61-67
3. Rutten, A.; Prokop, M. Contrast agents in X-ray computed tomography and its application in oncology Anti-Cancer Agents Med. Chem. 2007, 7, 307-316
4. Robinson, T. E. Computed tomography scanning techniques for the evaluation of cystic fibrosis lung disease Proc. Am. Thorac. Soc. 2007, 4, 310-315
5. Verschakelen, J. A.; De Wever, W.; Bogaert, J. Role of computed tomography in lung cancer staging Curr. Opin. Pulm. Med. 2004, 10, 248-255
6. Buschman, D. L. Barium sulfate bronchography. Report of a complication Chest 1991, 99, 747-749
7. Tamm, I.; Kortsik, C. Severe barium sulfate aspirationinto the lung: clinical presentation, prognosis and therapy Respiration 1999, 66, 81-84
8. McIntire, G. L.; Bacon, E. R.; Toner, J. L.; Cornacoff, J. B.; Losco, P. E.; Illig, K. J.; Nikula, K. J.; Muggenburg, B. A.; Ketai, L. Pulmonary delivery of nanoparticles of insoluble, iodinated CT X-ray contrast agents to lung draining lymph nodes in dogs J. Pharm. Sci. 1998, 87, 1466-1470
9. McIntire, G. L.; Bacon, E. R.; Illig, K. J.; Coffey, S. B.; Singh, B.; Bessin, G.; Shore, M. T.; Wolf, G. L. Time course of nodal enhancement with CT X-ray nanoparticle contrast agents: effect of particle size and chemical structure Invest. Radiol. 2000, 35, 91-96
10. Wisner, E. R.; Katzberg, R. W.; Koblik, P. D.; Shelton, D. K.; Fisher, P. E.; Griffey, S. M.; Drake, C.; Harnish, P. P.; Vessey, A. R.; Haley, P. J. Iodinated nanoparticles for indirect computed tomography lymphography of the craniocervical and thoracic lymph nodes in normal dogs Acad. Radiol. 1994, 1, 377-384
11. Liu, J.; Wong, H. L.; Moselhy, J.; Bowen, B.; Wu, X. Y.; Johnston, M. R. Targeting colloidal particulates to thoracic lymph nodes Lung Cancer 2006, 51, 377-386
12. Medina, L. A.; Calixto, S. M.; Klipper, R.; Phillips, W. T.; Goins, B. Avidin/biotin-liposome system injected in the pleural space for drug delivery to mediastinal lymph nodes J. Pharm. Sci. 2004, 93, 2595-2608
13. Videira, M. A.; Botelho, M. F.; Santos, A. C.; Gouveia, L. F.; de Lima, J. J.; Almeida, A. J. Lymphatic uptake of pulmonary delivered radiolabelled solid lipid nanoparticles J. Drug Targeing 2002, 10, 607-613
14. Videira, M. A.; Gano, L.; Santos, C.; Neves, M.; Almeida, A. J. Lymphatic uptake of lipid nanoparticles following endotracheal administration J Microencapsulation 2006, 23, 855-862
15. Szmigielski, W.; Klamut, M.; Siezieniewska, Z.; Chibowski, D.; Korobowicz, E.; Rubai, B.; Wolski, T.; Tynecka, Z. Powdered diatrizoic acid for radiography of the respiratory tract. Part I. experimental investigation Acta Radiol. 1991, 32, 415-420
16. Szmigielski, W.; Klamut, M.; Dahniya, M.; Klonowski, S.; Furmanik, F.; Kupisz, K.; Mahdi, O. Powdered diatrizoic acid for radiography of the respiratory tract. Part II. clinical application Acta Radiol. 1991, 32, 467-473
17. Ketai, L. H.; Muggenburg, B. A.; McIntire, G. L.; Bacon, E. R.; Rosenberg, R.; Losco, P. E.; Toner, J. L.; Nikula, K. J.; Haley, P. J. CT imaging of intrthoracic lymph nodes in dogs with bronchoscopically administered iodinated nanoparticles Acad. Radiol. 1999, 6, 49-54
18. El-Gendy, N.; Berkland, C. Combination chemotherapeutic dry powder aerosols via controlled nanoparticle agglomeration Pharm. Res. 2009, 26, 1752-1763
19. El-Gendy, N.; Gorman, E. M.; Munson, E. J.; Berkland, C. Budesonide nanoparticle agglomerates as dry powder aerosols with rapid dissolution J. Pharm. Sci. 2009, 98, 2731-2746
20. Plumley, C.; Gorman, E. M.; El-Gendy, N.; Bybee, C. R.; Munson, E. J.; Berkland, C. Nifedipine nanoparticle agglomeration as a dry powder aerosol formulation strategy Int. J. Pharm. 2009, 369, 136-143
21. Bailey, M. M.; Gorman, E. M.; Munson, E. J.; Berkland, C. Pure insulin nanoparticle agglomerates for pulmonary delivery Langmuir 2008, 24, 13614-13620
22. Peek, L. J.; Roberts, L.; Berkland, C. Poly(d, l -lactide- co -glycolide) nanoparticle agglomerates as carriers in dry powder aerosol formulation of proteins Langmuir 2008, 24, 9775-9783
23. Shi, L.; Plumley, C. J.; Berkland, C. Biodegradable nanoparticle flocculates for dry powder aerosol formulation Langmuir 2007, 23, 10897-10901
24. El-Gendy, N.; Aillon, K. L.; Berkland, C. Dry powdered aerosols of diatrizoic acid nanoparticle agglomerates as a lung contrast agent Int. J. Pharm. 2010, 391, 305-312
25. Hyafil, F.; Cornily, J. C.; Feig, J. E.; Gordon, R.; Vucic, E.; Amirbekian, V.; Fisher, E. A.; Fuster, V.; Feldman, L. J.; Fayad, Z. A. Noninvasive detection of macrophages using a nanoparticulate contrast agent for computed tomography Nat. Med. 2007, 13, 636-641
26. Hyafil, F.; Cornily, J. C.; Rudd, J. H.; Machac, J.; Feldman, L. J.; Fayad, Z. A. Quantification of inflammation within rabbit atherosclerotic plaques using the macrophage-specific CT contrast agent N1177: a comparison with 18F-FDG PET/CT and histology J. Nucl. Med. 2009, 50, 959-965
27. Van Herck, J. L.; De Meyer, G. R.; Martinet, W.; Salgado, R. A.; Shivalkar, B.; De Mondt, R.; Van De Ven, H.; Ludwig, A.; Van Der Veken, P.; Van Vaeck, L.; Bult, H.; Herman, A. G.; Vrints, C. J. Multi-slice computed tomography with N1177 identifies ruptured atherosclerotic plaques in rabbits Basic Res. Cardiol. 2010, 105, 51-59
28. Lechuga-Ballesteros, D.; Charan, C.; Stults, C. L.; Stevenson, C. L.; Miller, D. P.; Vehring, R.; Tep, V.; Kuo, M. C. Trileucine improves aerosol performance and stability of spray-dried powders for inhalation J. Pharm. Sci. 2008, 97, 287-302
29. Yang, Z. Y.; Le, Y.; Hu, T. T.; Shen, Z.; Chen, J. F.; Yun, J. Production of ultrafine Sumatriptan succinate particles for pulmonary delivery Pharm. Res. 2008, 25, 2012-2018
30. Pham, S.; Wiedmann, T. S. Note: dissolution of aerosol particles of budesonide in Survanta, a model lung surfactant J. Pharm. Sci. 2001, 90, 98-104
31. Vanbever, R.; Ben-Jebria, A.; Mintzes, J. D.; Langer, R.; Edwards, D. A. Sustained release of insulin from insoluble inhaled particles Drug Dev. Res. 1999, 48, 178-185
32. Tanaka, Y.; Inkyo, M.; Yumoto, R.; Nagai, J.; Takano, M.; Nagata, S. Nanoparticulation of poorly water soluble drugs using a wet-mill process and physicochemical properties of the nanopowders Chem. Pharm. Bull. (Tokyo) 2009, 57, 1050-1057
33. Trasi, N. S.; Boerrigter, S. X.; Byrn, S. R. Investigation of the milling-induced thermal behavior of crystalline and amorphous griseofulvin Pharm. Res. 2010, 27, 1377-1389
34. Fiegel, J.; Garcia-Contreras, L.; Thomas, M.; VerBerkmoes, J.; Elbert, K.; Hickey, A.; Edwards, D. Preparation and in vivo evaluation of a dry powder for inhalation of capreomycin Pharm. Res. 2008, 25, 805-811